GlassScriptPhysician profile
Genoveffa Morway
NPI 1619434008
$17,620.94
in general payments reported to CMS, 2019-2025
16 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $510 · 2023: $1,256 · 2024: $2,707 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $4,195 · Travel and Lodging: $2,150 · Education: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $4,195.26 |
| Travel and Lodging | $2,150.00 |
| Education | $766.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2025 | |
| Trimed, INC. | $3,860.80 | 2024-2025 | |
| Stryker Corporation | $2,124.80 | 2022-2024 | T2 Alpha, Gamma, Variax |
| Acumed LLC | $505.42 | 2025 | Acumed, Innate Implant |
| Alafair Biosciences, INC. | $188.39 | 2025 | Versawrap |
| Vericel Corporation | $152.37 | 2023 | Maci |
| Biomarin Pharmaceutical INC. | $149.47 | 2023 | Voxzogo 1.2mg |
| Depuy Synthes Sales INC. | $142.80 | 2025 | Va-Lcp |
| Endo USA, INC. | $137.94 | 2025 | Xiaflex |
| Kerecis Limited | $124.16 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Heron Therapeutics, INC. | $89.60 | 2024 | Zynrelef |
| Axogen | $54.00 | 2025 | |
| Sanara Medtech INC. | $28.62 | 2025 | Celleraterx |
| Vertex Pharmaceuticals Incorporated | $24.63 | 2024 | |
| Polynovo North America LLC | $20.24 | 2025 | Novosorb Btm |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paladin Technology Solutions | $17.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Genoveffa Morway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.